• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

Anatomical model of human arm and torso showing muscle
Biotech

Epicrispr gene silencer enhances muscle in muscular dystrophy

No other drug candidate has increased muscle mass in a facioscapulohumeral muscular dystrophy clinical trial, according to the company.
Darren Incorvaia Jun 26, 2026 10:40am
Graphic for The Top Line podcast featuring a pale blue background with a repeating pattern of blue-and-white capsules a

The deal before the deal

Jun 26, 2026 9:20am
Fosun
Favicon Fierce Pharma

Fosun Pharma plots global push, fueled by Alzheimer’s deals

Jun 25, 2026 7:00pm
An arrow incrementally going up stairs before pointing straight up Blue background

Otsuka posts phase 3b ADHD trial win ahead of looming FDA ruling

Jun 25, 2026 9:13am
Robotic hand stacking coins

With $15M, BI becomes latest to buy into Immunai’s AI platform

Jun 25, 2026 9:00am
Brain and money connected by a thread on a white background

Ionis bags $30M from Recordati for ex-US rare disease rights

Jun 25, 2026 6:59am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings